Evidence map›Paper›PMID 41852346›Full record

ArticleHaematologica2026

Efficacy and safety of chimeric antigen receptor T-cell therapy for plasma cell leukemia.

Chenyuan Hu, Na Qi, Wei Wang, Robert Peter Gale, Feng Zhu, Hujun Li, Hai Cheng, Jiang Cao, Zhiling Yan, Kunming Qi and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chenyuan HuDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cells, Xuzhou Medical University, Xuzhou.
Na QiDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Wei WangDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Department of Cardiology, The Affiliated Sihong Hospital of Xuzhou Medical University, Xuzhou.
Robert Peter GaleHaematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London.
Feng ZhuDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Hujun LiDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Hai ChengDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Jiang CaoDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Zhiling YanDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Kunming QiDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Wei SangDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou.
Kai ZhaoDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cells, Xuzhou Medical University, Xuzhou, China; Center for Sci-Tech Innovation and Public Service, The Affiliated Hospital of Xuzhou Medical University, Xuzhou. kainyzhao@163.com.
Wei ChenDepartment of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cells, Xuzhou Medical University, Xuzhou. feihu0808@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41852346
PMCPMC13530964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.